GO
Loading...

Enter multiple symbols separated by commas

Drug Retail

More

  • New Alzheimer's drugs timeline Friday, 12 Jun 2015 | 1:05 PM ET
    New Alzheimer's drugs timeline

    How Alzheimer's drug Solanezumab works to help treat the underlying cause of the disease, with CNBC's Meg Tirrell.

  • The Fed's wholesale issue with Costco Friday, 5 Jun 2015 | 10:00 AM ET
    The Fed's wholesale issue with Costco

    Costco has been subpoenaed by the federal government concerning prescriptions for controlled substances.

  • Helping doctors share cancer research Tuesday, 2 Jun 2015 | 1:18 PM ET
    Helping doctors share cancer research

    CNBC's Meg Tirrell provides insight to what Foundation Medicine, a cancer testing company, can do to better inform doctors on cancer via a database filled with research.

  • Two parts of Express Scripts' new plan Wednesday, 27 May 2015 | 1:01 PM ET
    Two parts of Express Scripts' new plan

    A new plan for Express Scripts regarding cancer drugs, with CNBC's Meg Tirrell.

  • CHICAGO, May 22- Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take such a public stand against the excessive use of drugs in raising farm animals. Wal-Mart, the country's biggest food retailer, is also telling suppliers not to raise animals in gestation crates or in...

  • Wal-Mart urges meat suppliers to curb antibiotic use Friday, 22 May 2015 | 1:42 PM ET

    CHICAGO, May 22- Wal-Mart Stores Inc is pressing meat, seafood, dairy and egg suppliers to reduce the use of antibiotics, becoming the first large retailer to take a stand against the excessive use of drugs in raising farm animals. Wal-Mart, the country's biggest food retailer, is also telling suppliers not to raise animals in gestation crates or in other...

  • *Deal values Omnicare at $12.7 bln, including $2.3 B debt. May 21- Drugstore operator CVS Health Corp said Thursday it will spend $10.1 billion to buy Omnicare Inc, a company that supplies prescription medicines to nursing, assisted living and other healthcare facilities. They could renegotiate their supply contracts given the volume, "said FBR analyst Steven...

  • GHIT: A fund for neglected tropical diseases Tuesday, 19 May 2015 | 9:47 PM ET
    GHIT: A fund for neglected tropical diseases

    BT Slingsby, CEO of the Global Health Innovative Technology Fund (GHIT), explains why it is developing new innovative health technologies to combat diseases like tuberculosis and malaria.

  • Biotech to watch ahead of ASCO Wednesday, 13 May 2015 | 2:36 PM ET
    Biotech to watch ahead of ASCO

    The American Society of Clinical Oncology conference will occur at the end of May in Chicago. CNBC's Meg Tirrell reports which companies investors should watch. Also, Les Funtleyder, ESquared Asset Management, shares his view.

  • How much do Americans spend on drugs? Wednesday, 13 May 2015 | 1:52 PM ET
    How much do Americans spend on drugs?

    A new report says the number of Americans being billed more than $100,000 a year for their prescriptions has tripled in the past year. CNBC's Meg Tirrell breaks down the report, saying slightly more than half of the spenders were men.

  • CARACAS, May 6- Venezuela is investigating whether drug companies including Germany's Merck KGaA and Bayer AG have improperly profited from subsidized foreign exchange amid growing medicine shortages, the country's health minister said. Those firms have received a favorable exchange rate through Venezuela's currency controls to produce or import...

  • May 1- CVS Health Corp reported higher-than-expected quarterly results on Friday, helped by increased revenue from its specialty pharmacy services and increased claim processing. CVS, the No. 2 U.S. drugstore operator, also raised the low end of its 2015 profit forecast to $5.08 a share from $5.05 before special items, while keeping the high end at 5.19.

  • April 9- Drugstore operator Walgreens Boots Alliance Inc on Thursday reported a higher-than-expected quarterly profit and said it would widen its cost-cutting program, sending its shares higher. Walgreens said on Thursday that it had identified ways to increase the program to a projected $1.5 billion by the August year-end of fiscal 2017..

  • April 8- Rite Aid Corp reported a better-than-expected quarterly profit on Wednesday, and expected a renewed distribution agreement with McKesson Corp along with the remodeling of its wellness stores to benefit fiscal 2016 earnings. Rite Aid is the No. 3 drugstore chain by sales in the U.S. behind Walgreen Boots Alliance and CVS Health Corp.

  • Rite Aid quarterly same-store sales rise 4.5 pct Wednesday, 8 Apr 2015 | 7:24 AM ET

    April 8- Drugstore chain operator Rite Aid Corp's quarterly revenue rose 3.8 percent, helped by strong prescription sales that drove better-than-expected same-store sales growth. Rite Aid's shares rose 2.9 percent to $8.95 in premarket trading on Wednesday. The latest quarter included an income tax benefit of $1.72 billion, or $1.67 per share, Rite Aid said.

  • FRANKFURT, March 27- Nine months after Apple and IBM began working together on building mobile apps for businesses, some of the first fruits are about to appear at UK pharmacy chain Boots, which has begun equipping store employees with iPads to serve shoppers in the aisles. Companies across dozens of different industries are now eyeing how these mobile business...

  • One iconic singer has high hopes for a pot brand Friday, 27 Mar 2015 | 8:43 AM ET
    Willie Nelson performs at the MusiCares 2015 Person Of The Year gala honoring Bob Dylan in Los Angeles, Feb. 6, 2015.

    Music icon Willie Nelson is going into the weed business, according to a pot activist.

  • Feb 17- CVS Health Corp, the second-largest U.S. pharmacy chain operator, has warned that a new class of drugs being developed to lower "bad" cholesterol could cost the U.S. healthcare system as much as $150 billion per year. The new class of cholesterol drugs called PCSK9 inhibitors could be priced in the range of $7,000- $12,000 per year, CVS said.

  • Feb 11- Drugstore operator Rite Aid Corp agreed to buy pharmacy benefit manager EnvisionRx for about $2 billion, looking to cut drug procurement costs as reimbursement rates fall. Rite Aid's deal comes nearly a decade after larger rival CVS Health Corp bought Caremark Rx for $21 billion, the only other example of a drug chain buying a benefits manager.

  • Feb 11- Drugstore operator Rite Aid Corp said it would buy pharmacy benefit manager EnvisionRx for about $2 billion, entering the business of administering health plan benefits. The deal will help Rite Aid compete better with CVS Health Corp, which bought Caremark Rx for $21 billion in 2006.. The acquisition of EnvisionRx will also give Rite Aid access to more...